A clinical study on modified growth hormone releasing factor (CJC-1295) demonstrated sustained increases in GH and IGF-1 levels following repeated dosing with a favorable safety profile, supporting the use of consistent dosing over multi-week protocols
Moderate damage/restoration: 500-750 mcg daily (split into 2-3 doses), lasting 4 weeks, then reduce to 250 mcg
Its well-tolerated by virtually all patients, with no significant side-effects reported in the research literature
Some users develop chronic constipation requiring fiber supplementation, increased water intake, or occasional use of osmotic laxatives like polyethylene glycol
Oral BPC-157 is often discussed for gastrointestinal concerns because it passes through the digestive tract and appears relatively stable in acidic environments
In fact, they will feel worse